Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2014

01.07.2014 | Brief Communication

Elevated Double Negative T Cells in Pediatric Autoimmunity

verfasst von: James A. Tarbox, Molly P. Keppel, Nermina Topcagic, Charles Mackin, Miriam Ben Abdallah, Kevin W. Baszis, Andrew J. White, Anthony R. French, Megan A. Cooper

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Autoimmune diseases are thought to be caused by a loss of self-tolerance of the immune system. One candidate marker of immune dysregulation in autoimmune disease is the presence of increased double negative T cells (DNTs) in the periphery. DNTs are characteristically elevated in autoimmune lymphoproliferative syndrome, a systemic autoimmune disease caused by defective lymphocyte apoptosis due to Fas pathway defects. DNTs have also been found in the peripheral blood of adult patients with systemic lupus erythematosus (SLE), where they may be pathogenic. DNTs in children with autoimmune disease have not been investigated.

Methods

We evaluated DNTs in pediatric patients with SLE, mixed connective tissue disease (MCTD), juvenile idiopathic arthritis (JIA), or elevated antinuclear antibody (ANA) but no systemic disease. DNTs (CD3+CD56TCRαβ+CD4CD8) from peripheral blood mononuclear cells were analyzed by flow cytometry from 54 pediatric patients including: 23 SLE, 15 JIA, 11 ANA and 5 MCTD compared to 28 healthy controls.

Results

Sixteen cases (29.6 %) had elevated DNTs (≥2.5 % of CD3+CD56TCRαβ+ cells) compared to 1 (3.6 %) control. Medication usage including cytotoxic drugs and absolute lymphocyte count were not associated with DNT levels, and percentages of DNTs were stable over time. Analysis of multiple phenotypic and activation markers showed increased CD45RA expression on DNTs from patients with autoimmune disease compared to controls.

Conclusion

DNTs are elevated in a subset of pediatric patients with autoimmune disease and additional investigations are required to determine their precise role in autoimmunity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Thomas JW. Antigen-specific responses in autoimmunity and tolerance. Immunol Res. 2001;23:235–44.PubMedCrossRef Thomas JW. Antigen-specific responses in autoimmunity and tolerance. Immunol Res. 2001;23:235–44.PubMedCrossRef
2.
Zurück zum Zitat Sieling PA, Porcelli SA, Duong BT, Spada F, Bloom BR, Diamond B, et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol. 2000;165:5338–44.PubMedCrossRef Sieling PA, Porcelli SA, Duong BT, Spada F, Bloom BR, Diamond B, et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol. 2000;165:5338–44.PubMedCrossRef
3.
Zurück zum Zitat Fleisher TA, Oliveira JB. Monogenic defects in lymphocyte apoptosis. Curr Opin Allergy Clin Immunol. 2012;12:609–15.PubMedCrossRef Fleisher TA, Oliveira JB. Monogenic defects in lymphocyte apoptosis. Curr Opin Allergy Clin Immunol. 2012;12:609–15.PubMedCrossRef
4.
Zurück zum Zitat Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, et al. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. Arthritis Rheum. 1999;42:1833–42.PubMedCrossRef Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, et al. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. Arthritis Rheum. 1999;42:1833–42.PubMedCrossRef
5.
Zurück zum Zitat Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35–40.PubMedCentralPubMedCrossRef Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35–40.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: a rare disorder providing clues about normal tolerance. Autoimmun Rev. 2010;9:488–93.PubMedCrossRef Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: a rare disorder providing clues about normal tolerance. Autoimmun Rev. 2010;9:488–93.PubMedCrossRef
7.
Zurück zum Zitat Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood. 2010;115:5164–9.PubMedCentralPubMedCrossRef Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood. 2010;115:5164–9.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Holzelova E, Vonarbourg C, Stolzenberg M-C, Arkwright PD, Selz F, Prieur A-M, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409–18.PubMedCrossRef Holzelova E, Vonarbourg C, Stolzenberg M-C, Arkwright PD, Selz F, Prieur A-M, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409–18.PubMedCrossRef
9.
Zurück zum Zitat Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181:8761–6.PubMedCentralPubMedCrossRef Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181:8761–6.PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Shivakumar S, Tsokos GC, Datta SK. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol. 1989;143:103–12.PubMed Shivakumar S, Tsokos GC, Datta SK. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol. 1989;143:103–12.PubMed
11.
Zurück zum Zitat Anand A, Dean G, Quereshi K, Isenberg D, Lydyard P. Characterization of CD3 + CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus. 2002;11:493–500.PubMedCrossRef Anand A, Dean G, Quereshi K, Isenberg D, Lydyard P. Characterization of CD3 + CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus. 2002;11:493–500.PubMedCrossRef
12.
Zurück zum Zitat Voelkl S, Gary R, Mackensen A. Characterization of the immunoregulatory function of human TCR-αβ + CD4–CD8- double-negative T cells. Eur J Immunol. 2011;41:739–48.PubMedCrossRef Voelkl S, Gary R, Mackensen A. Characterization of the immunoregulatory function of human TCR-αβ + CD4–CD8- double-negative T cells. Eur J Immunol. 2011;41:739–48.PubMedCrossRef
13.
Zurück zum Zitat Hillhouse EE, Lesage S. A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells. J Autoimmun. 2012;1–8. Hillhouse EE, Lesage S. A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells. J Autoimmun. 2012;1–8.
14.
Zurück zum Zitat Juvet SC, Zhang L. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions. J Mol Cell Biol. 2012;4:48–58.PubMedCentralPubMedCrossRef Juvet SC, Zhang L. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions. J Mol Cell Biol. 2012;4:48–58.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.PubMedCrossRef Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.PubMedCrossRef
16.
Zurück zum Zitat Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMed Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMed
17.
Zurück zum Zitat Seif AE, Manno CS, Sheen C, Grupp SA, Teachey DT. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood. 2010;115:2142–5.PubMedCrossRef Seif AE, Manno CS, Sheen C, Grupp SA, Teachey DT. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood. 2010;115:2142–5.PubMedCrossRef
18.
Zurück zum Zitat Niemela JE, Hsu AP, Fleisher TA, Puck JM. Single nucleotide polymorphisms in the apoptosis receptor gene TNFRSF6. Mol Cell Probes. 2006;20:21–6.PubMedCrossRef Niemela JE, Hsu AP, Fleisher TA, Puck JM. Single nucleotide polymorphisms in the apoptosis receptor gene TNFRSF6. Mol Cell Probes. 2006;20:21–6.PubMedCrossRef
19.
Zurück zum Zitat Appay V, Reynard S, Voelter V, Romero P, Speiser DE, Leyvraz S. Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples. J Clin Immunol. 2006;309:192–9. Appay V, Reynard S, Voelter V, Romero P, Speiser DE, Leyvraz S. Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples. J Clin Immunol. 2006;309:192–9.
20.
Zurück zum Zitat Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Brit J Haematol. 2009;148:205–16.CrossRef Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Brit J Haematol. 2009;148:205–16.CrossRef
21.
Zurück zum Zitat Bleesing JJ, Brown MR, Novicio C, Guarraia D, Dale JK, Straus SE, et al. A composite picture of TcRα/β + CD4-CD8- T Cells (α/β-DNTCs) in humans with Autoimmune Lymphoproliferative Syndrome. Clin Immunol. 2002;104:21–30.PubMedCrossRef Bleesing JJ, Brown MR, Novicio C, Guarraia D, Dale JK, Straus SE, et al. A composite picture of TcRα/β + CD4-CD8- T Cells (α/β-DNTCs) in humans with Autoimmune Lymphoproliferative Syndrome. Clin Immunol. 2002;104:21–30.PubMedCrossRef
22.
Zurück zum Zitat Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17:1290–7.PubMedCentralPubMedCrossRef Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17:1290–7.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Henson SM, Riddell NE, Akbar AN. Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol. 2012;24:476–81.PubMedCrossRef Henson SM, Riddell NE, Akbar AN. Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol. 2012;24:476–81.PubMedCrossRef
24.
Zurück zum Zitat Mehal WZ, Crispe IN. TCR ligation on CD8+ T cells creates double-negative cells in vivo. J Immunol. 1998;161:1686–93.PubMed Mehal WZ, Crispe IN. TCR ligation on CD8+ T cells creates double-negative cells in vivo. J Immunol. 1998;161:1686–93.PubMed
25.
Zurück zum Zitat Crispín JC, Tsokos GC. Human TCR-alpha beta + CD4–CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype. J Immunol. 2009;183:4675–81.PubMedCentralPubMedCrossRef Crispín JC, Tsokos GC. Human TCR-alpha beta + CD4–CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype. J Immunol. 2009;183:4675–81.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Pisitkun P, Ha H-L, Wang H, Claudio E, Tivy CC, Zhou H, et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity. 2012;37:1104–15.PubMedCentralPubMedCrossRef Pisitkun P, Ha H-L, Wang H, Claudio E, Tivy CC, Zhou H, et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity. 2012;37:1104–15.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M, et al. Isolation and characterization of human antigen-specific TCR alpha beta + CD4 (−) CD8-double-negative regulatory T cells. Blood. 2005;105:2828–35.PubMedCrossRef Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M, et al. Isolation and characterization of human antigen-specific TCR alpha beta + CD4 (−) CD8-double-negative regulatory T cells. Blood. 2005;105:2828–35.PubMedCrossRef
Metadaten
Titel
Elevated Double Negative T Cells in Pediatric Autoimmunity
verfasst von
James A. Tarbox
Molly P. Keppel
Nermina Topcagic
Charles Mackin
Miriam Ben Abdallah
Kevin W. Baszis
Andrew J. White
Anthony R. French
Megan A. Cooper
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2014
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0038-z

Weitere Artikel der Ausgabe 5/2014

Journal of Clinical Immunology 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.